----------------------------------------------------------------------------
        CALIPHO group at the SIB - Swiss Institute of Bioinformatics
        Geneva, Switzerland
----------------------------------------------------------------------------

 Description: Cellosaurus: a controlled vocabulary of cell lines
 Version: 12.0
 Last update: 10-Apr-2015

----------------------------------------------------------------------------
    _____     _ _
   / ____|   | | |
  | |     ___| | | ___  ___  __ _ _   _ _ __ _   _ ___
  | |    / _ \ | |/ _ \/ __|/ _` | | | | '__| | | / __|
  | |___|  __/ | | (_) \__ \ (_| | |_| | |  | |_| \__ \
   \_____\___|_|_|\___/|___/\__,_|\__,_|_|   \__,_|___/


 We have chosen to apply the Creative Commons Attribution-NoDerivs License
 (http://creativecommons.org/licenses/by-nd/3.0/) to this resource. This
 means that you are free to copy, distribute, display and make commercial
 use of the Cellosaurus in all legislations, provided you give us credit.
 However, if you intend to distribute a modified version of this database,
 you must ask us (ab@isb-sib.ch) for permission first.

 The definition of the Cellosaurus is provided in the following format:

 ---------  ---------------------------     ----------------------
 Line code  Content                         Occurrence in an entry
 ---------  ---------------------------     ----------------------
 ID         Identifier (cell line name)     Once; starts an entry
 AC         Accession (CVCL_xxxx)           Once
 SY         Synonyms                        Optional; once
 DR         Cross-references                Optional; once or more
 RX         References identifiers          Optional: once or more
 WW         Web pages                       Optional; once or more
 CC         Comments                        Optional; once or more
 DI         Diseases                        Optional; once or more
 OX         Species of origin               Once or more
 HI         Hierarchy                       Optional; once or more
 OI         Originate from same individual  Optional; once or more
 SX         Sex (gender) of cell            Optional; once
 CA         Category                        Optional; once
 //         Terminator                      Once; ends an entry

AN   Next free AC: CVCL_0Q68
_________________________________________________________________________
ID   #15310-LN
AC   CVCL_E548
SY   TER461
DR   dbMHC; 48439
DR   ECACC; 94050311
DR   IHW; IHW9326
DR   IMGT/HLA; 10074
WW   http://ml570.istge.it/ecbr/cl326.html
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
CA   Transformed cell line
//
ID   #490
AC   CVCL_B375
SY   Mab 7; Mab7
DR   CLO; CLO_0001018
DR   ATCC; HB-12029
RX   Patent=US5616470;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
//
ID   #822
AC   CVCL_X345
SY   Mab 13; Mab13
DR   ATCC; HB-12030
RX   Patent=US5616470;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
//
ID   #W7079
AC   CVCL_E549
SY   #W7079 REM; REMUS; W7079
DR   dbMHC; 48440
DR   ECACC; 94022552
DR   IHW; IHW9223
DR   IMGT/HLA; 11548
WW   http://ml570.istge.it/ecbr/cl223.html
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Sex undetermined
CA   Transformed cell line
//
ID   (BF1) 8A3.31
AC   CVCL_G217
DR   CLO; CLO_0001019
DR   ATCC; HB-9283
RX   Patent=US4845026;
OX   NCBI_TaxID=10090; ! Mus musculus
CA   Hybridoma
//
ID   +/+ (A)
AC   CVCL_6479
DR   CLO; CLO_0001020
DR   ATCC; CRL-6470
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6470; true.
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Sex undetermined
CA   Finite cell line
//
ID   +/+ (B)
AC   CVCL_6480
DR   CLO; CLO_0001021
DR   ATCC; CRL-6471
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6471; true.
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Sex undetermined
CA   Finite cell line
//
ID   +/+ (C)
AC   CVCL_S361
DR   ATCC; CRL-6472
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6472; true.
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Sex undetermined
CA   Finite cell line
//
ID   +/+ Li
AC   CVCL_4977
DR   CLO; CLO_0001022
DR   ATCC; CRL-6467
WW   http://www.lifetechnologies.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-340.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6467; true.
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Sex undetermined
CA   Finite cell line
//
ID   +/+ MGT
AC   CVCL_3627
DR   CLO; CLO_0001023
DR   ATCC; CRL-6468
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Female
CA   Cancer cell line
//
ID   +/+ SCT
AC   CVCL_3628
DR   CLO; CLO_0001024
DR   ATCC; CRL-6469
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Sex undetermined
CA   Cancer cell line
//
ID   [AD]FiPSAG07645-4F-17
AC   CVCL_V152
DR   ISCR; 2260
WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Lineas_ADFiPSAG07645-4F-17.pdf
CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_V148 ! AG07645
SX   Female
CA   Induced pluripotent stem cell
//
ID   [CRTRd]FiPS3067-4F-9
AC   CVCL_V153
DR   ISCR; 2261
WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/solicitud_deposito-CRTRd-FiPS3067-4F-9.pdf
CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
CA   Induced pluripotent stem cell
//
ID   [CRTRd]FiPS3819-4F-2
AC   CVCL_V154
SY   ESi003-A
DR   hESCreg; 1090
DR   ISCR; 2262
WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/solicitud_deposito_Lineas_CRTRd-FiPS3819-4F-2.pdf
CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
CA   Induced pluripotent stem cell
//
ID   [GA]FiPS4F
AC   CVCL_C792
SY   GA-FiPS4F; ESi030-A
DR   hESCreg; 1071
DR   ISCR; 2263
WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/GA_FiPS4F.pdf
CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI   NCIt; C99101; Glutaric acidemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
CA   Induced pluripotent stem cell
//
ID   [GD]FiPS-4F-21c
AC   CVCL_V156
SY   ESi004-A
DR   hESCreg; 1091
DR   ISCR; 2264
WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Linea_GD_FiPS-4F-21c.pdf
CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI   NCIt; C61268; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
CA   Induced pluripotent stem cell
//
ID   [PD]FiPS022-V4F-15
AC   CVCL_V157
DR   ISCR; 2265
WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Deposito-Linea-PDFiPS022-V4F-15.pdf
CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI   NCIt; C26845; Parkinson's disease
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
CA   Induced pluripotent stem cell
//
ID   00136
AC   CVCL_E557
SY   136
DR   dbMHC; 48441
DR   ECACC; 94071418
DR   IHW; IHW9279
DR   IMGT/HLA; 10002
WW   http://ml570.istge.it/ecbr/cl279.html
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Sex undetermined
CA   Transformed cell line
//
ID   022HU-NSO
AC   CVCL_6494
DR   CLO; CLO_0001025
DR   ATCC; CRL-11177
CC   Discontinued: ATCC; CRL-11177; probable.
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_3940 ! NS0
SX   Female
CA   Cancer cell line
//
ID   051407cb
AC   CVCL_V362
SY   970615NSB
DR   IMGT/HLA; 14462
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Sex undetermined
CA   Transformed cell line
//
ID   066
AC   CVCL_Y448
DR   ATCC; CRL-6287
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6287; true.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus
SX   Sex undetermined
CA   Undefined cell line type
//
ID   07-4D
AC   CVCL_J077
DR   ECACC; 91121239
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   090727 LQT3/BrS g1
AC   CVCL_T913
DR   SKIP; SKIP000214
CC   Discontinued: SKIP000214; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_T914 ! 090727 LQT3/BrS g2
CA   Induced pluripotent stem cell
//
ID   090727 LQT3/BrS g2
AC   CVCL_T914
DR   SKIP; SKIP000215
CC   Discontinued: SKIP000215; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_T913 ! 090727 LQT3/BrS g1
CA   Induced pluripotent stem cell
//
ID   1-1ras1000
AC   CVCL_8653
DR   JCRB; JCRB1355
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_0184 ! BALB/3T3 clone A31
CA   Spontaneously immortalized cell line
//
ID   1-1src
AC   CVCL_8654
DR   JCRB; JCRB1357
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_0184 ! BALB/3T3 clone A31
CA   Spontaneously immortalized cell line
//
ID   1-29-7
AC   CVCL_Y308
DR   ATCC; HB-63
CC   Discontinued: ATCC; HB-63; probable.
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
//
ID   1-5c-4
AC   CVCL_2260
SY   Clone 1-5c-4; Clone 1-5c-4 WKD of Chang Conjunctiva
DR   CLO; CLO_0002500
DR   CLO; CLO_0002501
DR   CLDB; cl793
DR   CLDB; cl794
DR   CLDB; cl795
DR   ATCC; CCL-20.2
DR   ECACC; 88021103
DR   IZSLER; BS CL 93
DR   KCLB; 10020.2
RX   PubMed=566722;
RX   PubMed=20143388;
CC   Problematic cell line: contaminated. Shown to be a HeLa derivative (PubMed 566722, PubMed 20143388).
DI   NCIt; C4029; Cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0030 ! HeLa
SX   Female
CA   Cancer cell line
//
ID   1-7HB2
AC   CVCL_2261
SY   1-7 HB2; HB2
DR   ECACC; 10081201
WW   http://www.cancertechnology.com/1-7-hb2-cell-line
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_8645 ! MTSV1-7
SX   Female
CA   Transformed cell line
//
ID   1-8
AC   CVCL_T367
DR   CLO; CLO_0050510
DR   RCB; RCB1374
RX   PubMed=8973332;
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops
HI   CVCL_0229 ! CV-1
SX   Male
CA   Transformed cell line
//
ID   1-87
AC   CVCL_D231
DR   CHEMBL; CHEMBL612272
DR   Cosmic; 889083
DR   Cosmic; 946049
DR   Cosmic; 1066155
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Cancer cell line
//
ID   1-LN
AC   CVCL_L211
SY   1LN; 1-LN-PC-3-1A
DR   BTO; BTO:0005352
RX   PubMed=4007233;
CC   Derived from metastatic site: bone.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0035 ! PC-3
SX   Male
CA   Cancer cell line
//
ID   1.1B4
AC   CVCL_1778
DR   ECACC; 00112811
DR   ECACC; 10012801
RX   Patent=US20040005702;
RX   PubMed=21515691;
CC   Discontinued: ECACC; 00112811; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0480 ! PANC-1
SX   Male
CA   Hybrid cell line
//
ID   1.1E7
AC   CVCL_2257
DR   ATCC; PTA-3523
DR   ECACC; 10070101
RX   Patent=US20040005702;
RX   PubMed=21515691;
CC   Discontinued: ATCC; PTA-3523; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0480 ! PANC-1
SX   Male
CA   Hybrid cell line
//
ID   1.2B4
AC   CVCL_2258
DR   ATCC; PTA-3524
DR   ECACC; 10070103
RX   Patent=US20040005702;
CC   Discontinued: ATCC; PTA-3524; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_1299 ! HuP-T3
SX   Male
CA   Hybrid cell line
//
ID   1.4E7
AC   CVCL_2259
DR   ATCC; PTA-3525
DR   ECACC; 10070102
RX   Patent=US20040005702;
RX   PubMed=21515691;
CC   Discontinued: ATCC; PTA-3525; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0480 ! PANC-1
SX   Male
CA   Hybrid cell line
//
ID   10-1.D.2
AC   CVCL_B376
DR   CLO; CLO_0001027
DR   ATCC; TIB-165
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   10-2.16
AC   CVCL_B377
DR   CLO; CLO_0001028
DR   ATCC; TIB-93
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   10-3.6.2
AC   CVCL_B378
DR   CLO; CLO_0001029
DR   ATCC; TIB-92
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   10.014 pRSV-T
AC   CVCL_6341
SY   10.014
DR   CLO; CLO_0001026
DR   ATCC; CRL-11515
RX   Patent=US5672498;
RX   PubMed=9143482;
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Transformed cell line
//
ID   10.84
AC   CVCL_J168
SY   10.84.2
DR   ATCC; HB-8387
RX   Patent=US4650676;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
//
ID   10/9CRC1
AC   CVCL_8478
DR   BTO; BTO:0004581
RX   PubMed=15860353;
OX   NCBI_TaxID=10090; ! Mus musculus
CA   Cancer cell line
//
ID   10(AAT) Clone A
AC   CVCL_U069
DR   ECACC; 02043015
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   100-1#16
AC   CVCL_T867
SY   100-1 #16
DR   SKIP; SKIP000192
RX   PubMed=22848530;
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_T866 ! 100-1#8
SX   Female
CA   Induced pluripotent stem cell
//
ID   100-1#8
AC   CVCL_T866
SY   100-1 #8
DR   SKIP; SKIP000191
RX   PubMed=22848530;
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_T867 ! 100-1#16
SX   Female
CA   Induced pluripotent stem cell
//
ID   100-2#1
AC   CVCL_T868
SY   100-2 #1
DR   SKIP; SKIP000193
RX   PubMed=22848530;
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
CA   Induced pluripotent stem cell
//
ID   100-310
AC   CVCL_N280
DR   ATCC; HB-11028
RX   Patent=US5565356;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   100213 LQT2 theta10
AC   CVCL_T915
DR   SKIP; SKIP000217
CC   Discontinued: SKIP000217; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_T916 ! 100213 LQT2 theta4
CA   Induced pluripotent stem cell
//
ID   100213 LQT2 theta4
AC   CVCL_T916
DR   SKIP; SKIP000216
CC   Discontinued: SKIP000216; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_T915 ! 100213 LQT2 theta10
CA   Induced pluripotent stem cell
//
ID   1011-mel
AC   CVCL_7942
SY   1011-MEL; 1011 mel; 1011mel; 1011; Mel 1011
DR   CGH-DB; 9292-4
DR   Cosmic; 876687
DR   Cosmic; 905206
RX   PubMed=8081556;
RX   PubMed=15467732;
CC   Derived from metastatic site: not described.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Cancer cell line
//
ID   1013L
AC   CVCL_4806
DR   Cosmic; 721372
RX   PubMed=14518029;
WW   http://capcelllines.ca/details.asp?id=78
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
CA   Cancer cell line
//
ID   101A
AC   CVCL_J815
RX   PubMed=6189834;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   103-LCL
AC   CVCL_6751
DR   CLO; CLO_0050492
DR   RCB; RCB2082
DR   TKG; TKG 0614
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Transformed cell line
//
ID   104C1
AC   CVCL_2267
DR   CLO; CLO_0001030
DR   ATCC; CRL-1405
DR   CCRID; 3111C0002000000046
DR   CCRID; 3142C0001000000091
DR   ECACC; 90110524
DR   JCRB; JCRB9036
OX   NCBI_TaxID=10141; ! Cavia porcellus
SX   Female
CA   Transformed cell line
//
ID   105AJ
AC   CVCL_M609
RX   PubMed=8689636;
DI   NCIt; C2946; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_M605 ! 105KC
SX   Female
CA   Cancer cell line
//
ID   105AJ1.1
AC   CVCL_M610
RX   PubMed=8689636;
DI   NCIt; C2946; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_M609 ! 105AJ
SX   Female
CA   Cancer cell line
//
ID   105AJ3.1
AC   CVCL_M611
RX   PubMed=8689636;
DI   NCIt; C2946; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_M609 ! 105AJ
SX   Female
CA   Cancer cell line
//
ID   105AJ5.1
AC   CVCL_M612
RX   PubMed=8689636;
DI   NCIt; C2946; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_M609 ! 105AJ
SX   Female
CA   Cancer cell line
//
ID   105KC
AC   CVCL_M605
SY   105 KC; KC
RX   PubMed=2045389;
RX   PubMed=16039953;
DI   NCIt; C2946; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
CA   Cancer cell line
//
ID   1066
AC   CVCL_E424
SY   DUGE
DR   dbMHC; 48442
DR   ECACC; 94071403
DR   IHW; IHW9340
DR   IMGT/HLA; 10022
WW   http://ml570.istge.it/ecbr/cl340.html
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Sex undetermined
CA   Transformed cell line
//
ID   1088-mel
AC   CVCL_8029
SY   1088-MEL; 1088 Mel; 1088 mel; 1088
DR   Cosmic; 876702
RX   PubMed=8081556;
RX   PubMed=10048982;
CC   Derived from metastatic site: not described.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Cancer cell line
//
ID   108CC5
AC   CVCL_4076
SY   NG108-5
DR   ECACC; 08062521
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_1970 ! C6-BU-1
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
//
ID   108CC5-BU
AC   CVCL_4077
DR   ECACC; 08062566
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5-BU-5
AC   CVCL_4078
DR   ECACC; 08062567
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5-BU-8
AC   CVCL_4079
DR   ECACC; 08062569
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5-TG-1
AC   CVCL_4082
DR   ECACC; 08062543
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5-TG-2
AC   CVCL_4083
DR   ECACC; 08062544
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5-TG-3
AC   CVCL_4084
DR   ECACC; 08062545
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5-TG-4
AC   CVCL_4085
DR   ECACC; 08062546
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5T-BU-1
AC   CVCL_4080
DR   ECACC; 08062570
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   108CC5T-BU-4
AC   CVCL_4081
DR   ECACC; 08062571
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
//
ID   10B10
AC   CVCL_6819
RX   PubMed=12543551;
WW   http://www.copewithcytokines.de/cope.cgi?key=10B10
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
CA   Cancer cell line
//
ID   10B9
AC   CVCL_B379
DR   CLO; CLO_0001031
DR   ATCC; HB-172
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
//
ID   10C4.1.3
AC   CVCL_H997
DR   CLO; CLO_0001032
DR   ATCC; HB-11029
RX   Patent=US5578704;
RX   Patent=US5652110;
RX   PubMed=7683273;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
//
ID   10C7
AC   CVCL_D146
DR   CLO; CLO_0001033
DR   ATCC; CRL-2430
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
//
ID   10C9
AC   CVCL_R704
DR   ATCC; CRL-10236
RX   Patent=US5108920;
CC   Discontinued: ATCC; CRL-10236; probable.
DI   NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Cancer cell line
//
ID   10D2F6
AC   CVCL_G563
DR   CLO; CLO_0001034
DR   ATCC; HB-11103
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   10E2
AC   CVCL_Y303
RX   PubMed=6248199;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_Y304 ! BLP
CA   Spontaneously immortalized cell line
//
ID   10E5
AC   CVCL_G016
DR   CLO; CLO_0001035
DR   ATCC; HB-8513
RX   Patent=US4596769;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   10F7MN
AC   CVCL_G564
DR   CLO; CLO_0001036
DR   ATCC; HB-8162
RX   Patent=US4767710;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   10G4
AC   CVCL_U285
RX   Patent=WO2013155882A1;
CC   Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201016.
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   10H
AC   CVCL_N538
DR   CLO; CLO_0050298
DR   RCB; RCB0705
RX   PubMed=6206890;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   10H-2
AC   CVCL_N539
DR   CLO; CLO_0050283
DR   RCB; RCB1142
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   10H2.12.1
AC   CVCL_H998
DR   CLO; CLO_0001037
DR   ATCC; HB-11494
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
//
ID   10P12
AC   CVCL_6481
DR   CLO; CLO_0001038
DR   ATCC; CRL-2036
RX   PubMed=2998805;
OX   NCBI_TaxID=10090; ! Mus musculus
CA   Transformed cell line
//
ID   10P2
AC   CVCL_6482
DR   CLO; CLO_0001039
DR   ATCC; CRL-2034
DR   BCRC; 60316
RX   PubMed=2998805;
OX   NCBI_TaxID=10090; ! Mus musculus
CA   Transformed cell line
//
ID   10P8
AC   CVCL_0E96
DR   ATCC; CRL-2035
RX   PubMed=2998805;
CC   Discontinued: ATCC; CRL-2035; true.
OX   NCBI_TaxID=10090; ! Mus musculus
CA   Transformed cell line
//
ID   11-18
AC   CVCL_A596
DR   CGH-DB; 201-1
DR   CGH-DB; 9163-4
DR   Cosmic; 889084
DR   Cosmic; 946048
DR   Cosmic; 1066156
DR   Cosmic; 1336877
DR   Cosmic; 1656892
DR   Cosmic; 1731372
RX   PubMed=14581340;
RX   PubMed=15746151;
RX   PubMed=22313637;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Cancer cell line
//
ID   11-18-ER1-7
AC   CVCL_D856
SY   11-18/ER1-7
DR   Cosmic; 1731373
RX   PubMed=22815900;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_A596 ! 11-18
CA   Cancer cell line
//
ID   11-18-ER2-1
AC   CVCL_D857
SY   11-18/ER2-1
DR   Cosmic; 1731374
RX   PubMed=22815900;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_A596 ! 11-18
CA   Cancer cell line
//
ID   11-18-GEF10-1
AC   CVCL_D776
SY   11-18/GEF10-1
DR   Cosmic; 1731375
RX   PubMed=22815900;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_A596 ! 11-18
CA   Cancer cell line
//
ID   11-18-GEF20-1
AC   CVCL_D777
SY   11-18/GEF20-1
DR   Cosmic; 1731376
RX   PubMed=22815900;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_A596 ! 11-18
CA   Cancer cell line
//
ID   11-18/R
AC   CVCL_S745
SY   11-18R; 11-18/ER
DR   Cosmic; 1890459
RX   PubMed=22773810;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_A596 ! 11-18
CA   Cancer cell line
//
ID   11-26c
AC   CVCL_9138
DR   CLO; CLO_0001043
DR   ATCC; HB-250
OX   NCBI_TaxID=129429; ! Mouse/rat hybrid cell lines
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
//
ID   11-4
AC   CVCL_2819
DR   ECACC; 11033102
CC   Transfected with: UniProtKB; P08659; firefly luciferase.
DI   NCIt; C4029; Cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0030 ! HeLa
SX   Female
CA   Cancer cell line
//
ID   11-4.1
AC   CVCL_G219
DR   CLO; CLO_0001044
DR   ATCC; TIB-95
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   11-5.2.1.9
AC   CVCL_G189
DR   CLO; CLO_0001045
DR   ATCC; TIB-94
DR   ECACC; 89050905
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   11-5F
AC   CVCL_J078
DR   ECACC; 91121236
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
//
ID   11-9-1-4
AC   CVCL_5948
SY   11.9.14
DR   BTO; BTO:0002603
DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_1092 ! BT-549
SX   Female
CA   Cancer cell line
//
ID   11.9
AC   CVCL_N790
DR   ATCC; CRL-2705
CC   Discontinued: ATCC; CRL-2705; true.
OX   NCBI_TaxID=10090; ! Mus musculus
CA   Embryonic stem cell
//
ID   110-5
AC   CVCL_J035
DR   CLO; CLO_0001040
DR   ATCC; HB-8984
RX   Patent=US5180663;
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
//
ID   1102-mel
AC   CVCL_8030
SY   1102-MEL; 1102 mel; 1102mel; 1102; MEL1102
DR   BTO; BTO:0002947
DR   CGH-DB; 9293-4
DR   Cosmic; 905207
DR   Cosmic; 972280
RX   PubMed=8081556;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=15467732;
CC   Derived from metastatic site: not described.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens
CA   Cancer cell line
//
ID   11028
AC   CVCL_L307
RX   PubMed=169374;
CC   Breed/subspecies: Saint Bernard.
OX   NCBI_TaxID=9615; ! Canis familiaris
SX   Male
CA   Cancer cell line
//
ID   11031
AC   CVCL_L308
RX   PubMed=169374;
CC   Breed/subspecies: Saint Bernard.
OX   NCBI_TaxID=9615; ! Canis familiaris
SX   Male
CA   Cancer cell line
//
ID   1107F-HA
AC   CVCL_G344
DR   TKG; TKG 0303
OX   NCBI_TaxID=10090; ! Mus musculus
CA   Hybridoma
//
ID   111 BLCL
AC   CVCL_E341
DR   ECACC; 94031620
RX   PubMed=8588125;
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
CA   Transformed cell line
//
ID   1116NS-19-9
AC   CVCL_G218
SY   1116-NS-19-9
DR   CLO; CLO_0001041
DR   ATCC; HB-8059
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
//
